ALSO NOTED: FDA expands use of Plavix; Merck touts Fosamax data; and much more...
> The FDA has approved the use of Plavix for certain types of heart attacks. Report
> Merck is touting new data that shows Fosamax helped build bone density in the spines of volunteers using steroids to treat arthritis. Report
> GlaxoSmithKline dropped its bid to patent the AIDS drug Combid in Thailand and India after its move sparked protests on the parts of AIDS advocates. Report
> Poniard Pharmaceuticals has completed enrollment in a Phase II trial for small cell lung cancer. Release
And Finally… Researchers at Duke University Medical Center in Durham have used siRNAs to kill prostate cancer cells in mice. Article
Paid Research Reports
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets
- The Emerging Role of Postmarketing Clinical Research: Regulatory issues, strategic drivers and overall trends


Rate it: